Valeant continues disposals with Dendreon sale

Canada’s beleaguered Valeant Pharmaceuticals International has continued its moves to offload non-core assets with the sale of the maker of the Provenge pancreatic cancer treatment Dendreon Pharmaceuticals. Valeant, which was…